Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2023-11-22 4:15 pm Sale | 13D | Chinook Therapeutics, Inc. KDNY | Samsara BioCapital L.P. | 0 0.000% | -5,181,557 (Position Closed) | View |
| 2023-08-11 5:17 pm Purchase | 13D | Chinook Therapeutics, Inc. KDNY | Farallon Capital Partners L.P. | 7,110,000 9.900% | 7,110,000 (New Position) | View |
| 2023-08-01 08:56 am Purchase | 13G | Chinook Therapeutics, Inc. KDNY | BAILLIE GIFFORD & CO | 844,684 2.000% | 844,684 (New Position) | View |
| 2023-03-10 4:13 pm Sale | 13D | Chinook Therapeutics, Inc. KDNY | Versant Venture Capital VII L.P. | 2,105,107 3.200% | -240,000 (-10.23%) | View |
| 2023-02-14 4:12 pm Sale | 13G | Chinook Therapeutics, Inc. KDNY | Point72 Asset Management L.P. | 1,299,548 2.000% | -1,817,932 (-58.31%) | View |
| 2023-02-14 12:05 pm Purchase | 13G | Chinook Therapeutics, Inc. KDNY | Frazier Life Sciences Public Fund L.P. | 4,052,510 6.300% | 1,282,484 (+46.30%) | View |
| 2023-02-14 08:42 am Purchase | 13G | Chinook Therapeutics, Inc. KDNY | Deep Track Capital LP | 3,000,000 4.690% | 247,930 (+9.01%) | View |
| 2023-02-01 4:54 pm Purchase | 13G | Chinook Therapeutics, Inc. KDNY | BlackRock Inc. BLK | 3,954,741 6.200% | 966,810 (+32.36%) | View |
| 2022-12-28 4:07 pm Sale | 13D | Chinook Therapeutics, Inc. KDNY | Versant Venture Capital VII L.P. | 2,345,107 3.700% | -567,963 (-19.50%) | View |
| 2022-08-22 4:15 pm Unchanged | 13D | Chinook Therapeutics, Inc. KDNY | Versant Venture Capital VII L.P. | 2,913,070 4.600% | 0 (Unchanged) | View |
| 2022-06-07 4:45 pm Purchase | 13G | Chinook Therapeutics, Inc. KDNY | Point72 Asset Management L.P. | 3,117,480 5.100% | 3,117,480 (New Position) | View |
| 2022-06-01 4:00 pm Purchase | 13D | Chinook Therapeutics, Inc. KDNY | Samsara BioCapital L.P. | 5,181,557 8.400% | 5,181,557 (New Position) | View |
| 2022-04-29 12:19 pm Purchase | 13G | Chinook Therapeutics, Inc. KDNY | Frazier Life Sciences Public Fund L.P. | 2,770,026 5.000% | 2,770,026 (New Position) | View |
| 2022-04-13 4:43 pm Sale | 13D | Chinook Therapeutics, Inc. KDNY | Versant Venture Capital VII L.P. | 2,913,070 5.300% | -709,953 (-19.60%) | View |
| 2022-02-22 06:13 am Sale | 13D | ADURO BIOTECH, INC ADRO | Morningside Venture (VI) Investments Ltd | 15,078 0.030% | -2,969,527 (-99.49%) | View |
| 2022-02-16 4:46 pm Purchase | 13G | Chinook Therapeutics, Inc. KDNY | Deep Track Capital LP | 2,752,070 5.040% | 2,752,070 (New Position) | View |
| 2022-02-04 4:12 pm Purchase | 13G | Chinook Therapeutics, Inc. KDNY | BlackRock Inc. BLK | 2,987,931 5.600% | 2,987,931 (New Position) | View |
| 2022-01-21 4:01 pm Sale | 13G | Chinook Therapeutics, Inc. KDNY | ATP Life Science Ventures L.P. | 0 0.000% | -4,028,937 (Position Closed) | View |
| 2022-01-13 4:30 pm Sale | 13D | Chinook Therapeutics, Inc. KDNY | Versant Venture Capital VII L.P. | 3,623,023 6.700% | -600,000 (-14.21%) | View |
| 2021-09-07 5:13 pm Sale | 13D | Chinook Therapeutics, Inc. KDNY | Versant Venture Capital VII L.P. | 4,223,023 9.400% | -510,000 (-10.78%) | View |